Investitionsthese
MHV invests in UK-based health tech founders with global ambitions, enabling transatlantic growth by leveraging partnerships with leading NHS trusts and US health systems (e.g., Cedars-Sinai, Hartford HealthCare). The fund supports evidence generation for broader adoption, aligning portfolio companies with health systems from inception to scale.
Investitionsphase
Early-stage to growth-stage health tech ventures
Bevorzugte Reifephase für die erste Finanzierung.
Sektoren & Themen
Clinical innovators focused on adoption and scale of transformative health tech solutions
Thematische Schwerpunkte und Zielmarktsegmente von Interesse.
Ticketgröße
€4.130.000 - €7.350.000
Standard-Finanzierungsbetrag pro Runde.
Outreach & Dossier-Analysen
Verifiziertes E-Mail-Muster
Analysen-Scorecard der Investitionsthese
Unser KI-Analyzer hat Portfolio-Unternehmen gescannt und verifizierte Übereinstimmungen berechnet...